SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
Hui Li(Tianjin Medical University Cancer Institute and Hospital), Haihe Wang(Sun Yat-sen University)
Cited by 40
Related Papers
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
|Cancer Immunology Immunotherapy|2020|71
Independent oncogenic and therapeutic significance of phosphatase PRL‐3 in FLT3‐ITD–negative acute myeloid leukemia
|Cancer|2014|43
Integrative analysis of multi-omics data reveals inhibition of RB1 signaling promotes apatinib resistance of hepatocellular carcinoma
|International Journal of Biological Sciences|2023|6